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Despite controversies about the accuracy of quantitative estimates
there seems to be a broad consensus that occupational cancer
‘tends to be concentrated among relatively small groups of people
among whom the risk of developing the disease may be quite large,
and such risks can usually be reduced or even eliminated, once
they have been identified. The detection of occupational hazards
should therefore have a higher priority in any programme of
cancer prevention than their proportional importance might
suggest (Doll and Peto, 1981). Moreover, low risk experienced by
large numbers of workers exposed at low levels can also contribute
substantially to an overall burden of cancer.
To pursue this aim, the British Health and Safety Executive
(HSE) initiated a strategic approach to reduce the incidence of
occupational cancer in Great Britain and to determine priorities
for preventing occupational cancer based on sound evidence. To
this end, Rushton et al (2010) at Imperial College London, the
Institute of Occupational Medicine, the Institute of Environment
and Health and the Health and Safety Laboratory carried out a
comprehensive estimate of the burden of occupational cancer in
Britain.
As part of this project two HSE-sponsored workshops were held
in November 2004 and June 2006 that brought together national
and international experts to discuss the issues relevant to the
project and to advise on the appropriate methodology and data
requirements. Many of the participants from the two workshops
contributed advice throughout the project, particularly regarding
selection of appropriate risk estimates and allocation of exposure
levels to industry sectors. Earlier results of this project by Rushton
et al (2008) have now been updated and extended, based on
incidence in Britain in 2004 and mortality in 2005 (Rushton et al,
2010).
One of the major strengths of this project is its rigorous
methodology coupled with full transparency in the approach.
Briefly, Rushton et al estimated attributable fractions and
numbers for incidence and mortality for agents and occupations
classified as Group 1 or 2A carcinogens by the International
Agency for Research on Cancer (IARC) Monographs programme
with ‘sufficient’ or ‘limited’ evidence for specific cancers in
humans. Risk estimates for low and high exposures were obtained
from published literature and de novo meta-analyses taking into
account validity of the studies and their relevance to the UK.
National data sources (UK-CAREX (CARcinogen Exposure
Database), the annual Labour Force Survey (LFS) and the Census
of Employment) were used for estimating the proportion of the
population exposed taking into account risk exposure periods
(REP), assuming a latency of 10–50 years for solid tumours and
0–20 years for haematopoietic neoplasms. LFS data were also used
to account for employment turnover and changes in numbers
employed in the different industry sectors and occupations.
Attributable fractions for mesothelioma were derived directly
from several UK studies that suggested that between 85 and 90% of
male mesothelioma cases are due to occupational exposure, and a
ratio of 1:1 for mesothelioma to lung cancer deaths has been used
for the estimation of lung cancers attributable to asbestos.
This project also had to face several important methodological
challenges, particularly lack of or uncertainties about historical
exposure prevalences and levels, and the choice of the most
appropriate relative risks for low and high exposures during
the REP.
The major findings are:
1. more than 8% of all cancer deaths in men are due to
occupational exposures, and for lung cancer, the most
important occupational cancer, the estimate for men is above
20%;
2. several of the most important occupational carcinogens are
relevant beyond the workplace resulting in household (e.g.,
asbestos) and environmental exposures (e,g., diesel engine
exhaust);
3. the evidence on occupational carcinogenic hazards is still
incomplete and newly identified occupational carcinogens,
including ones beyond the typical chemical carcinogens, may
contribute additional substantial burden, particularly if ex-
posures are widespread and affected cancer sites are common,
even if the strength of association is only moderate (e.g., shift-
work that involves circadian disruption leading to female breast
cancer).
There are many more carcinogens classified as IARC Group 2B
than Groups 1 and 2A combined (IARC, 2012), including many
with potential occupational exposure and other exposures not yet
evaluated by IARC and perhaps not immediately recognised as
potential occupational carcinogens (e.g., sedentary work and
colorectal cancer). These, together with the Group 2A carcinogens
and sites with ‘limited evidence’ are obvious priorities for
additional research and amongst those prioritisation can also be
guided by the estimated burden. *Correspondence: Dr K Straif; E-mail: straifk@iarc.fr
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approach for occupational cancer control. With lung cancer as the
most important occupational cancer and treatment outcomes for
this cancer still being very poor and the effectiveness of lung
cancer screening in the occupational setting still debated, primary
prevention remains the best tool to reduce occupational lung
cancer mortality. The use and manufacture of asbestos, historically
the most important occupational carcinogen, has been strictly
reduced in the UK since the 1970s. In the past, asbestos exposure
occurred within industries such as shipbuilding, railway engineer-
ing and asbestos product manufacture. Workers with the highest
risks today are likely to be those subject to incidental exposures
during the course of their work, for example, building main-
tenance workers. Because of the long latency, the peak of asbestos-
related cancers is still to come (Tan et al, 2010). This example may
also help to understand why there are so few studies directly
showing successful reduction of occupational cancer following
effective intervention. However, given the robust evidence on the
carcinogenic hazard of these exposures, monitoring progress is
probably best achieved by monitoring exposure prevalence and
levels. In this context, results of an analysis of the HSE National
Exposure Database showing that for 12 of the top 19 carcinogens
(Cherrie et al, 2007) the average exposure levels between 1986 and
2001 were above the current British occupational exposure limit
are alarming and the new strategic initiative by HSE is both
appreciated and needed.
Because of its sophisticated and rigorous methods the
approach presented here in detail by Rushton et al has already
led to similar projects in other countries (Ja ¨rvholm et al, 2012) and
is being adapted for the estimation of the global burden of
occupational cancer. An updated, refined and expanded CAREX
database would be instrumental in demonstrating progress
towards controlling occupational cancer in the UK and worldwide
although this would need to be continuously updated to ensure the
currency of the data on prevalences and levels of exposure to
carcinogens.
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